Correlation Between Alnylam Pharmaceuticals and Ascendis Pharma
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Ascendis Pharma AS, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Ascendis Pharma.
Diversification Opportunities for Alnylam Pharmaceuticals and Ascendis Pharma
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Alnylam and Ascendis is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Ascendis Pharma go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and Ascendis Pharma
Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to under-perform the Ascendis Pharma. In addition to that, Alnylam Pharmaceuticals is 1.39 times more volatile than Ascendis Pharma AS. It trades about -0.19 of its total potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.03 per unit of volatility. If you would invest 12,944 in Ascendis Pharma AS on August 28, 2024 and sell it today you would earn a total of 141.00 from holding Ascendis Pharma AS or generate 1.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alnylam Pharmaceuticals vs. Ascendis Pharma AS
Performance |
| Timeline |
| Alnylam Pharmaceuticals |
| Ascendis Pharma AS |
Alnylam Pharmaceuticals and Ascendis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alnylam Pharmaceuticals and Ascendis Pharma
The main advantage of trading using opposite Alnylam Pharmaceuticals and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
| Ascendis Pharma vs. Eliem Therapeutics | Ascendis Pharma vs. HCW Biologics | Ascendis Pharma vs. Scpharmaceuticals | Ascendis Pharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |